Abstract: There is presented a hearing device for being placed at least partially in an ear canal. The hearing device includes a rechargeable battery, and at least two charging areas on the surface of the hearing device, the charging areas enabling recharging the rechargeable battery by applying a voltage from one charging area to another charging area. At least one charging area is positioned on the hearing device at the end of the hearing device facing into the middle ear during use and optionally out of contact with the walls of the ear canal during use.

Abstract: Disclosed is an FSR sensor compatible with a magnetic stimulation coil and intended to be fixed to a magnetic stimulation coil and including: a first layer made of biocompatible flexible material intended to be applied to the skin of a patient; a second layer including a pattern or an area of force sensitive or resistive ink; a third layer including adhesive material, forming a peripheral spacer element; a fourth layer made of a flexible heat-stable polycarbonate substrate with a printed conductive pattern of a force sensing circuit; and a fifth layer forming an adhesive surface on the bottom face. The pattern of the second layer is carried by a semi-flexible plate of heat-stable polycarbonate material, constituting an intermediate pressure distribution layer, the plate being adhesively stuck to the fourth layer and to the first layer, the peripheral spacer defining an air gap between the second and fourth layers.

Abstract: Disclosed is an FSR sensor compatible with a magnetic stimulation coil and intended to be fixed to a magnetic stimulation coil and including: a first layer made of biocompatible flexible material intended to be applied to the skin of a patient; a second layer including a pattern or an area of force sensitive or resistive ink; a third layer including adhesive material, forming a peripheral spacer element; a fourth layer made of a flexible heat-stable polycarbonate substrate with a printed conductive pattern of a force sensing circuit; and a fifth layer forming an adhesive surface on the bottom face. The pattern of the second layer is carried by a semi-flexible plate of heat-stable polycarbonate material, constituting an intermediate pressure distribution layer, the plate being adhesively stuck to the fourth layer and to the first layer, the peripheral spacer defining an air gap between the second and fourth layers.

Abstract: A networked items dispenser is disclosed. The device includes a housing having a bulk storage bin for storing items, a temporary storage bin for receiving the items, and a dispensing receptacle for receiving the items from the temporary storage bin. A communications network interface is provided for entering programming instructions. A programmable internal memory device is also included for storing a schedule for dispensing the items, such that the schedule can be automatically adjusted according to a hierarchy of dispensing rules.

Abstract: An automated small items dispensing apparatus is disclosed. In a preferred embodiment, the invention includes a networked, programmable, automatic medication items dispensing apparatus for use by individual patients who are enrolled in a medication protocol or medication therapy regimen. The device is located separate from the patient's health care provider's facility, such as in the patient's home.

Abstract: The present invention relates to the field of enhanced electrical power receptacles and associated plugs. Specifically it relates to power receptacles that are easy to identify and use. It achieves these features with a receptacle that has the individual prong-holes identified and differentiated with light source or markings in a scheme that allows the user to quickly locate and identify the proper prong-holes. The associated plug can be labeled with markings for orientation. The receptacle lighting or pattern scheme will help the user easily locate the receptacle and orient the associated plug for accurate and rapid insertion.

Abstract: An automated small items dispensing apparatus is disclosed. In a preferred embodiment, the invention includes a networked, programmable, automatic medication items dispensing apparatus for use by individual patients who are enrolled in a medication protocol or medication therapy regimen. The device is located separate from the patient's health care provider's facility, such as in the patient's home.

Abstract: A networked items dispenser is disclosed. The device includes a housing having a bulk storage bin for storing items, a temporary storage bin for receiving the items, and a dispensing receptacle for receiving the items from the temporary storage bin. A communications network interface is provided for entering programming instructions. A programmable internal memory device is also included for storing a schedule for dispensing the items, such that the schedule can be automatically adjusted according to a hierarchy of dispensing rules.

Abstract: Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c, each independently, range from 0 to 2, and L is a chiral ligand having the formula (1), where Cn together with the two 2 O-atoms and the P-atom forms a substituted or non-substituted ring with 2-4 C-atoms, R1 and R2 each independently represent H, an optionally substituted alkyl, aryl, alkaryl or aralkyl group or may form a (heterocyclic) ring together with the N-atom to which they are bound. And a process for the asymmetric (transfer) hydrogenation of an olefinically unsaturated compound, ketone, imine or oxime derivate in the presence of a hydrogen donor and of a catalyst, use being made of a catalyst represented by formula MLaXbSc, where M is a transition metal, to be chosen from rhodium, iridium and ruthenium, X is a counter ion, S is a ligand, a ranges from 0.

Abstract: Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c, each independently, range from 0 to 2, and L is a chiral ligand having the formula (1), where Cn together with the two 2 O-atoms and the P-atom forms a substituted or non-substituted ring with 2-4 C-atoms, R1 and R2 each independently represent H, an optionally substituted alkyl, aryl, alkaryl or aralkyl group or may form a (heterocyclic) ring together with the N-atom to which they are bound. And a process for the asymmetric (transfer) hydrogenation of an olefinically unsaturated compound, ketone, imine or oxime derivate in the presence of a hydrogen donor and of a catalyst, use being made of a catalyst represented by formula MLaXbSc, where M is a transition metal, to be chosen from rhodium, iridium and ruthenium, X is a counter ion, S is a ligand, a ranges from 0.